PEAK6 Investments’s Novavax NVAX Stock Holding History

PEAK6 Investments’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-21,400	Closed	-$271K	–	3914
2024 Q2	$271K	Sell	21,400 -184,100	-90%	-$1.85M	﹤0.01%	2606
2024 Q1	$982K	Buy	+205,500	New	+$953K	﹤0.01%	1947
2023 Q1	–	Sell	-28,600	Closed	-$294K	–	4761
2022 Q4	$294K	Buy	+28,600	New	+$505K	﹤0.01%	2976
2022 Q3	–	Sell	-48,300	Closed	-$2.48M	–	5749
2022 Q2	$2.48M	Sell	48,300 -51,800	-52%	-$2.68M	﹤0.01%	2082
2022 Q1	$7.37M	Sell	100,100 -5,700	-5%	-$508K	0.02%	850
2021 Q4	$15.1M	Buy	105,800 +10,300	+11%	+$1.77M	0.03%	526
2021 Q3	$19.8M	Buy	95,500 +42,200	+79%	+$9.3M	0.04%	398
2021 Q2	$11.3M	Buy	+53,300	New	+$9.77M	0.03%	619

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

PEAK6 Investments's NVAX Position: Q3 2024 in Review

PEAK6 Investments increased its Novavax (NVAX) stake by 27% in Q3 2024, buying an estimated $62.5K and bringing the position to 23,000 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #2609.

PEAK6 Investments first reported a position in NVAX in Q2 2021 and has held it in 10 quarters since. The position peaked at $11.8M in Q3 2021. 238 funds tracked by Wall St. Rank hold NVAX as of Q3 2024.

PEAK6 Investments held 23,000 shares of Novavax worth $290K as of Q3 2024.
PEAK6 Investments bought 4,837 Novavax shares in Q3 2024, an estimated $62.5K.
Novavax made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2609 holding.
PEAK6 Investments first reported a position in Novavax in Q2 2021 and has held it in 10 quarters since.
PEAK6 Investments's Novavax position peaked at $11.8M in Q3 2021.
238 funds tracked by Wall St. Rank held Novavax as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.